Where Patent Law Draws the Line for Compounded Medications: A Strategic Analysis of Regulatory Exemptions, Intellectual Property Rights, and Market Realities
In the complex landscape of healthcare innovation and patient access, the line between patent law and compounded medications has never been more blurred—or more critical to understand.
The Growing Tension Between Innovation and Access
Pharmaceutical co…
